MEMBER LOG IN
USERNAME:
PASSWORD:
FORGET YOUR PASSWORD?
Unique collection development tool featuring the most extensive database of expert reviews of books, eBooks, and software in the health sciences, now with over 46,000 reviews.
Bibliographic information on over 220,000 book, eBook, and software titles in 126 specialties.
Weekly email reporting on new reviews and new titles in your areas of interest.
Discover e-versions of books available from your favorite aggregators!
Click here for a complete listing.
Includes Doody's Core Titles 2025
Annual subscription allows up to 5 users at your institution to sign up for their own weekly updates.
Quick and Advanced search engines; List Manager to create, store, share and e-mail lists of titles.
Manage your subscription online: add/delete users; print invoices and submit payments.
eBook/Digital Version available from:
 
Web Site

Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States
ISBN: 978-0-309-71896-7, 400 pages, Soft Cover
ISBN-10: 0-309-71896-1
Copyright: 2025
Edition: 1st
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
500 5th Street, NW
Keck 360
Washington, DC 20001
UNITED STATES
P: 8006246242 F: 202-334-2793
http://www.nap.edu
List Price: $42.00
Google:
Checking for Limited Preview at Google
View Large Size

View Citation Citation

At A Glance

Infant formula is a primary or supplementary source of nutrition for many infants in the U.S. Consequently, disruptions to the supply of infant formula can have a severe impact on infants' health and well-being. In late 2021 and early 2022, a recall of specific infant formula products, followed by a pause in production, resulted in a widespread, national shortage. The incident demonstrated that additional risk management planning is needed to protect infants from the consequences of potential future supply chain disruptions.

In 2023, the U.S. Food and Drug Administration contracted with the National Academies to convene an expert committee to examine and report on challenges in supply, market competition, and regulation of infant formula. The resulting consensus study report explains policy and marketplace vulnerabilities that were exposed during the shortage, describes the extent to which actions taken by relevant stakeholders addressed these vulnerabilities, identifies remaining gaps in the system, and recommends actions to reduce the risk and lessen the effect of any future disruption to the infant formula supply chain.

Learn more and order here.